Safety, Tolerability, and Pharmacokinetics of MW11 in Patients With Advanced Solid Tumors
Clinical trial NCT04478461 · UNKNOWN
Trial details
- NCT number
- NCT04478461
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2023-01-05
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.